News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
183,035 Results
Type
Article (15974)
Company Profile (13)
Press Release (167048)
Section
Business (49199)
Career Advice (320)
Deals (7563)
Drug Delivery (28)
Drug Development (24432)
Employer Resources (30)
FDA (3822)
Job Trends (4072)
News (84366)
Policy (6715)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (1)
2024 Biotech Bay Standard (1)
Academia (1758)
Accelerated approval (1)
Adcomms (11)
Allergies (20)
Alliances (15458)
ALS (19)
Alzheimer's disease (542)
Antibody-drug conjugate (ADC) (28)
Approvals (3840)
Artificial intelligence (82)
Autoimmune disease (4)
Automation (5)
Bankruptcy (84)
Best Places to Work (3469)
BIOSECURE Act (14)
Biosimilars (13)
Biotechnology (9)
Bladder cancer (23)
Brain cancer (13)
Breast cancer (84)
Cancer (769)
Cardiovascular disease (51)
Career advice (286)
Career pathing (4)
CAR-T (53)
Cell therapy (136)
Cervical cancer (12)
Clinical research (19452)
Collaboration (260)
Compensation (36)
Complete response letters (2)
COVID-19 (1099)
CRISPR (12)
C-suite (67)
Cystic fibrosis (26)
Data (629)
Depression (5)
Diabetes (56)
Diagnostics (1942)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (10)
Drug discovery (33)
Drug pricing (33)
Drug shortages (2)
Duchenne muscular dystrophy (13)
Earnings (12915)
Editorial (7)
Employer branding (3)
Employer resources (25)
Events (23250)
Executive appointments (167)
FDA (4131)
Featured Employer (2)
Friedreich's ataxia (3)
Frontotemporal dementia (3)
Funding (292)
Gene editing (24)
Generative AI (3)
Gene therapy (102)
GLP-1 (165)
Government (1354)
Grass and pollen (1)
Guidances (14)
Healthcare (5817)
Huntington's disease (3)
IgA nephropathy (7)
Immunology and inflammation (18)
Indications (6)
Infectious disease (1134)
Inflammatory bowel disease (35)
Inflation Reduction Act (3)
Influenza (6)
Intellectual property (21)
Interviews (33)
IPO (3649)
IRA (21)
Job creations (719)
Job search strategy (266)
Kidney cancer (7)
Labor market (8)
Layoffs (92)
Legal (1193)
Liver cancer (23)
Lung cancer (112)
Lymphoma (51)
Machine learning (2)
Management (10)
Manufacturing (72)
MASH (13)
Medical device (3242)
Medtech (3244)
Mergers & acquisitions (4058)
Metabolic disorders (125)
Multiple sclerosis (18)
NASH (4)
Neurodegenerative disease (13)
Neuropsychiatric disorders (2)
Neuroscience (665)
NextGen: Class of 2025 (1914)
Non-profit (2031)
Northern California (612)
Now hiring (5)
Obesity (58)
Opinion (62)
Ovarian cancer (34)
Pain (24)
Pancreatic cancer (20)
Parkinson's disease (41)
Partnered (9)
Patents (34)
Patient recruitment (36)
Peanut (13)
People (17583)
Pharmaceutical (6)
Pharmacy benefit managers (1)
Phase I (7103)
Phase II (8590)
Phase III (5688)
Pipeline (334)
Policy (51)
Postmarket research (681)
Preclinical (2635)
Press Release (20)
Prostate cancer (39)
Psychedelics (10)
Radiopharmaceuticals (96)
Rare diseases (94)
Real estate (1437)
Recruiting (12)
Regulatory (4684)
Reports (13)
Research institute (1900)
Resumes & cover letters (39)
Rett syndrome (3)
RNA editing (1)
RSV (5)
Schizophrenia (13)
Series A (50)
Series B (21)
Sickle cell disease (21)
Southern California (512)
Special edition (1)
Spinal muscular atrophy (34)
Sponsored (5)
Startups (1218)
Stomach cancer (3)
Supply chain (14)
Tariffs (1)
United States (5666)
Vaccines (219)
Venture capitalists (12)
Webinars (3)
Weight loss (30)
Women's health (3)
Worklife (3)
Date
Today (28)
Last 7 days (208)
Last 30 days (792)
Last 365 days (9258)
2025 (2242)
2024 (9688)
2023 (11436)
2022 (15095)
2021 (16032)
2020 (15298)
2019 (13876)
2018 (10271)
2017 (9251)
2016 (9106)
2015 (10683)
2014 (7833)
2013 (6469)
2012 (6640)
2011 (6945)
2010 (5986)
Location
Africa (207)
Alabama (32)
Alaska (3)
Arizona (59)
Arkansas (3)
Asia (11220)
Australia (2607)
California (1340)
Canada (424)
China (97)
Colorado (60)
Connecticut (60)
Delaware (45)
Europe (24900)
Florida (266)
Georgia (41)
Idaho (13)
Illinois (132)
India (6)
Indiana (113)
Iowa (1)
Japan (48)
Kansas (29)
Kentucky (11)
Louisiana (2)
Maine (10)
Maryland (228)
Massachusetts (995)
Michigan (38)
Minnesota (77)
Missouri (27)
Montana (8)
Nebraska (5)
Nevada (7)
New Hampshire (16)
New Jersey (570)
New Mexico (6)
New York (442)
North Carolina (196)
North Dakota (4)
Northern California (612)
Ohio (60)
Oklahoma (5)
Oregon (10)
Pennsylvania (323)
Rhode Island (7)
South America (293)
South Carolina (5)
South Dakota (1)
Southern California (512)
Tennessee (22)
Texas (264)
Utah (32)
Virginia (36)
Washington D.C. (34)
Washington State (182)
West Virginia (2)
Wisconsin (9)
183,035 Results for "max planck institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Okami Medical Announces Portfolio Expansion with the Addition of the SENDERO® MAX Delivery Catheter
March 25, 2025
·
2 min read
Press Releases
MAXONA PHARMACEUTICALS ANNOUNCES MAX-OO1 PHASE 1 CLINICAL PROGRAM RESULTS
March 19, 2025
·
5 min read
Press Releases
MAXONA PHARMACEUTICALS GRANTED FIFTH PATENT FOR FIRST TO MARKET PRODUCT MAX-001
February 26, 2025
·
3 min read
Press Releases
Metaba and MAX BioPharma Announce Breakthrough Progress on Next-Generation Oxysterol-Based Antibiotics
February 20, 2025
·
3 min read
Press Releases
The Max Foundation (Max) Expands Collaboration with Novartis to Include Access to Innovative Treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH)
December 6, 2024
·
3 min read
Business
Immunome Announces Promotion of Max Rosett to Chief Financial Officer
Immunome, Inc. today announced the promotion of Max Rosett to Chief Financial Officer, effective May 9.
May 17, 2024
·
5 min read
Press Releases
MAXONA PHARMACEUTICALS EMERGES FROM STEALTH AS IT ACHIEVES MILESTONE IN DEVELOPMENT OF FIRST-TO-MARKET CANDIDATE MAX-001
February 11, 2025
·
6 min read
Press Releases
Advanced Instruments Releases the OsmoPRO® MAX Automated Osmometer to Enhance Clinical Lab Productivity
January 27, 2025
·
2 min read
Business
Orthofix Names Max Reinhardt President of Global Spine Business
Orthofix Medical Inc today announced the appointment of Max Reinhardt as President of the Global Spine business effective June 10, 2024.
May 23, 2024
·
4 min read
BiondVax’s Strategic Research Collaboration with Max Planck and UMG: Significant progress towards development of innovative nanosized antibodies (NanoAbs) for therapeutic indications in addition to COVID-19
BiondVax Pharmaceuticals Ltd. provided encouraging updates related to the strategic research collaboration between BiondVax, the Max Planck Institute for Multidisciplinary Sciences, and the University Medical Center Göttingen towards the development of a pipeline of innovative alpaca–derived nanosized antibody therapies.
September 20, 2022
·
6 min read
1 of 18,304
Next
